Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2023-10-23FDA Approved: FULVESTRANT — Supplemental Application (Accord Healthcare Inc.)
The FDA approved a supplemental application for Fulvestrant from Accord Healthcare Inc., updating the labeling for this generic product.
-
FDA approval · 2023-10-23FDA Approved: CAPECITABINE — Original Application (Teyro Labs Private Limited)
FDA approved the original application (ANDA) for a generic capecitabine product manufactured by Teyro Labs Private Limited.
-
CLINICAL_TRIALS trial_result · 2023-10-19Clinical Trial Update: SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer [Phase 3]
Phase 3 trial comparing SYD985 to physician's choice in HER2-positive metastatic breast cancer has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-10-19Clinical Trial Update: The Role of Emotional Processing in Improving the Quality of Life of Breast Cancer Patients [NA]
A completed clinical trial investigating how emotional processing affects quality of life in breast cancer patients with depressive symptoms…
-
CLINICAL_TRIALS trial_result · 2023-10-17Clinical Trial Update: Stereotactic Radiosurgery vs Whole Brain Radiotherapy in Breast Cancer With Brain Oligometastasis [Phase 3]
Phase 3 trial comparing stereotactic radiosurgery versus whole brain radiotherapy in breast cancer with brain oligometastases.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-10-17Clinical Trial Update: Neoadjuvant Tucidinostat and Exemestane in Early Breast Cancer [Phase 2]
Phase 2 neoadjuvant trial evaluating tucidinostat plus exemestane in early breast cancer has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2023-10-16Clinical Trial Update: ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBC [Phase 2]
Phase 2 trial comparing ACHP-THP to EC-THP as neoadjuvant therapy for HER2-positive early breast cancer (EBC); status ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS trial_result · 2023-10-16Clinical Trial Update: Trigger Point Injections for Post-Mastectomy Pain Syndrome [Phase 2]
Phase 2 clinical trial update for trigger point injections addressing post-mastectomy pain syndrome and myofascial pain syndrome in breast c…
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. [Phase 1, Phase 2]
A Phase I/II study evaluating atezolizumab in combination with olaparib in patients with advanced solid tumors, including ovarian, breast, s…
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response [Phase 4]
Phase 4 clinical trial update evaluating neoadjuvant weekly paclitaxel in breast cancer with biomarkers of therapy response; recruitment is …
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Performance of Contrast-Enhanced Spectral Mammography to Assess Neoadjuvant Chemotherapy Response (CEDM) [Phase 4]
A Phase 4 trial assessing contrast-enhanced spectral mammography to evaluate neoadjuvant chemotherapy response in breast cancer has terminat…
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery [Phase 1, Phase 2]
Clinical trial comparing T-DM1 alone versus T-DM1 with metronomic temozolomide in HER2-positive breast cancer brain metastases after stereot…
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Olive Oil for High Risk Breast Cancer Prevention in Women [Phase 2, Phase 3]
A trial update on olive oil for high-risk breast cancer prevention in women completed phases 2 and 3 with results posted.
-
CLINICAL_TRIALS trial_result · 2023-10-06Clinical Trial Update: Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer [Phase 3]
Phase 3 trial evaluating denosumab to preserve normal bone mineral density in women with breast cancer receiving adjuvant aromatase inhibito…
-
CLINICAL_TRIALS trial_result · 2023-10-05Clinical Trial Update: Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating capecitabine, cyclophosphamide, lapatinib ditosylate, and trastuzumab in HER2-positive metastatic breast cancer has…
-
CLINICAL_TRIALS trial_result · 2023-10-05Clinical Trial Update: A Prospective, Multi-site Clinical Study to Collect User Feedback Using Affirm® Contrast Biopsy [NA]
A completed multi-site clinical study collecting user feedback on Affirm Contrast Biopsy in breast cancer patients; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-10-04Clinical Trial Update: Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting [Phase 2]
Phase 2 neoadjuvant trial evaluating carboplatin and nab-paclitaxel with either trastuzumab for HER2-positive or bevacizumab for HER2-negati…
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy [Phase 2]
A Phase 2 clinical trial update focusing on personalized target therapy and immunotherapy approaches across breast and gastrointestinal canc…
-
FDA approval · 2023-10-02FDA Approved: OGIVRI — Supplemental Application (Biocon Biologics Inc.)
FDA approved a supplemental Biologics License Application for OGIVRI (trastuzumab-dkst) from Biocon Biologics Inc. The biosimilar is intende…
-
CLINICAL_TRIALS trial_result · 2023-10-02Clinical Trial Update: Rural Interventions for Screening Effectiveness [NA]
Completed clinical trial evaluating rural interventions to improve screening effectiveness for breast, cervical, or colorectal cancer; resul…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer [Phase 2]
Phase 2 randomized trial of genomically directed therapy in triple-negative breast cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: 18F-fluoroestradiol (FES) PET/CT for Breast Cancer [Phase 2]
Phase 2 clinical trial update for 18F-fluoroestradiol PET/CT in breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Pilot Study Using Molecular Profiling to Find Potential Targets & Select Treatments for Pts With Met br ca [EARLY_Phase 1]
Pilot early-phase study exploring molecular profiling to identify targets and tailor treatments for metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: IMX-110 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update for IMX-110 in adults with advanced solid tumors across Phase 1 and Phase 2 is listed, with multiple solid tumor ind…
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral Metastasis [Phase 4]
Phase 4 clinical study evaluating Huaier Granules in patients with advanced breast cancer without visceral metastasis.